An overview of the mTOR pathway as a target in cancer therapy.
about
mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic InterventionsPI3K and cancer: lessons, challenges and opportunitiesThe evolution of the TOR pathway and its role in cancer.Intersection of mTOR and STAT signaling in immunityTuberous Sclerosis: A New Frontier in Targeted Treatment of AutismTargeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.Acute myeloid leukemia: potential for new therapeutic approaches targeting mRNA translation pathways.Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer.Use of mTOR inhibitors in the treatment of malignancies.Targeting the mTOR Pathway in Leukemia.PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor.High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma.Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients.Too much or too little: harnessing senescence to control oncogene-driven cancer.Catalytic mammalian target of rapamycin inhibitors as antineoplastic agents.Effect of puerarin on human choriocarcinoma cells.5'-methylschweinfurthin G reduces chondrosarcoma tumor growth .
P2860
Q27007511-370687A5-FBF1-4462-AB6C-2BE5429CC2AAQ30080017-C562D40E-E4B3-4AAB-A40C-D5EFAF17DB4FQ34318188-3C2F1826-5A15-405C-84A2-944702D2CC85Q34978661-2B55AC54-DFAC-4E60-9929-676908461F38Q35811772-41225F6F-09B1-4585-BAF5-316A827A21A3Q36214081-8D265BDD-D258-40C1-AE4F-2CB403301DAFQ37364509-FA232CAC-621C-4784-AF65-6B23E70BF2AEQ38094782-80FD8414-932A-4FB2-8624-862165D57CACQ38199196-BB2F8C2C-E344-43A0-8780-41637E029B91Q38790630-0033BCF9-89B7-4302-9F39-0C1826B952B7Q39087858-22EA7BE0-008F-41DB-AC64-A4C234D74356Q41846880-4D7F4A20-1B0D-4C06-999B-5FED358AF43FQ41913207-9D75B677-DF97-438B-BF19-1E08B79101F4Q42446395-FBA3E337-A2FC-4BC0-9613-9BDFB4341C85Q48101340-0C7315F6-EDB9-4AF4-87AB-3315843C20B3Q51082279-A973B15B-D3E4-44F6-9F5E-3C94B4AFC9EAQ51781084-C2F5F003-AF48-4016-9333-902B43066286
P2860
An overview of the mTOR pathway as a target in cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An overview of the mTOR pathway as a target in cancer therapy.
@en
type
label
An overview of the mTOR pathway as a target in cancer therapy.
@en
prefLabel
An overview of the mTOR pathway as a target in cancer therapy.
@en
P2860
P1476
An overview of the mTOR pathway as a target in cancer therapy
@en
P2093
Jessica K Altman
Leonidas C Platanias
P2860
P304
P356
10.1517/14728222.2012.677439
P407
P577
2012-04-12T00:00:00Z